Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AngioDynamics Forecasts Fiscal Year 2025 Adjusted EPS Of $(0.38)-$(0.42), Compared To Fiscal 2024 Pro Forma Adjusted EPS Of $(0.45) Versus Consensus Of $(0.49)

Author: Benzinga Newsdesk | July 16, 2024 06:48am

Posted In: ANGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist